- Reduction in C-reactive protein and low-density lipoprotein cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin trial. Obstetrical and Gynecological Survey. 2009 Comment GET IT
- Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. Obstetrical and Gynecological Survey. 2009 Comment GET IT
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
New England Journal of Medicine.
Times cited: 3933
Clinical imaging for prevention: Directed strategies for improved detection of presymptomatic patients with undetected atherosclerosis-Part I: Clinical imaging for prevention.
Journal of Nuclear Cardiology.
Times cited: 14
From Vulnerable Plaque to Vulnerable Patient-Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report.
American Journal of Cardiology.
Times cited: 435